Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista española de quimioterapia 2023-12, Vol.36 (6), p.645-647
Hauptverfasser:	Moreno Izarra, J, Brunst, A, Carmona Álvarez, J A, Aranda, F, Mártir Alario, J M
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Anti-Bacterial Agents - therapeutic use Glycopeptides - therapeutic use Humans Lipoglycopeptides - therapeutic use Methicillin-Resistant Staphylococcus aureus Neoplasms - drug therapy Soft Tissue Infections - complications Soft Tissue Infections - drug therapy Staphylococcal Infections - drug therapy Staphylococcus aureus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	647
container_issue	6
container_start_page	645
container_title	Revista española de quimioterapia
container_volume	36
creator	Moreno Izarra, J Brunst, A Carmona Álvarez, J A Aranda, F Mártir Alario, J M
description
doi_str_mv	10.37201/req/055.2023
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2876638057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2876638057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c218t-79affacfc88810aca3547714f693753343220f15fed0c6989abf9e7445cfa66c3</originalsourceid><addsrcrecordid>eNo9kb1uFDEURi0EIkugpEUuaSbx34xtOhQSghSJglCP7nqvE8OMPbE9QftMvGQcsqH6int0dKVDyHvOTqQWjJ9mvDtlfX8imJAvyIZbYzrbc_OSbJjgqpNK2CPyppRfjCmpLH9NjqQ23FgzbMjfL-hDDPGGRvxD6y1mWHCtwdHiMEIOqVCfMk05VLiH6EL8RAveY0a6BVfbzg3-UWG53U_JJefWQmHN2Kb8DpFC3NGSfKU1lLIiDdGjqyFF-ng8uKY9DfO8xiaYl5zmUHBHU3RpSjd7ukANGOtb8srDVPDdYY_Jz4vz67PL7ur7129nn686J7ipnbbgPTjvjDGcgQPZK6258oOVupdSSSGY573HHXODNRa23qJWqncehsHJY_Lxyds-uVux1LH943CaIGJayyiMHgZpWK8b2j2hLqdSMvpxyWGGvB85G__1GVufsfUZH_s0_sNBvW5n3P2nn4PIB5AokaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876638057</pqid></control><display><type>article</type><title>Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Moreno Izarra, J ; Brunst, A ; Carmona Álvarez, J A ; Aranda, F ; Mártir Alario, J M</creator><creatorcontrib>Moreno Izarra, J ; Brunst, A ; Carmona Álvarez, J A ; Aranda, F ; Mártir Alario, J M</creatorcontrib><identifier>ISSN: 0214-3429</identifier><identifier>EISSN: 1988-9518</identifier><identifier>DOI: 10.37201/req/055.2023</identifier><identifier>PMID: 37818986</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Glycopeptides - therapeutic use ; Humans ; Lipoglycopeptides - therapeutic use ; Methicillin-Resistant Staphylococcus aureus ; Neoplasms - drug therapy ; Soft Tissue Infections - complications ; Soft Tissue Infections - drug therapy ; Staphylococcal Infections - drug therapy ; Staphylococcus aureus</subject><ispartof>Revista española de quimioterapia, 2023-12, Vol.36 (6), p.645-647</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0005-7502-2946 ; 0009-0001-4750-6485 ; 0009-0002-1545-4542 ; 0009-0007-2607-1025 ; 0009-0001-1080-3128</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37818986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moreno Izarra, J</creatorcontrib><creatorcontrib>Brunst, A</creatorcontrib><creatorcontrib>Carmona Álvarez, J A</creatorcontrib><creatorcontrib>Aranda, F</creatorcontrib><creatorcontrib>Mártir Alario, J M</creatorcontrib><title>Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient</title><title>Revista española de quimioterapia</title><addtitle>Rev Esp Quimioter</addtitle><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Glycopeptides - therapeutic use</subject><subject>Humans</subject><subject>Lipoglycopeptides - therapeutic use</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Neoplasms - drug therapy</subject><subject>Soft Tissue Infections - complications</subject><subject>Soft Tissue Infections - drug therapy</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcus aureus</subject><issn>0214-3429</issn><issn>1988-9518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kb1uFDEURi0EIkugpEUuaSbx34xtOhQSghSJglCP7nqvE8OMPbE9QftMvGQcsqH6int0dKVDyHvOTqQWjJ9mvDtlfX8imJAvyIZbYzrbc_OSbJjgqpNK2CPyppRfjCmpLH9NjqQ23FgzbMjfL-hDDPGGRvxD6y1mWHCtwdHiMEIOqVCfMk05VLiH6EL8RAveY0a6BVfbzg3-UWG53U_JJefWQmHN2Kb8DpFC3NGSfKU1lLIiDdGjqyFF-ng8uKY9DfO8xiaYl5zmUHBHU3RpSjd7ukANGOtb8srDVPDdYY_Jz4vz67PL7ur7129nn686J7ipnbbgPTjvjDGcgQPZK6258oOVupdSSSGY573HHXODNRa23qJWqncehsHJY_Lxyds-uVux1LH943CaIGJayyiMHgZpWK8b2j2hLqdSMvpxyWGGvB85G__1GVufsfUZH_s0_sNBvW5n3P2nn4PIB5AokaA</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Moreno Izarra, J</creator><creator>Brunst, A</creator><creator>Carmona Álvarez, J A</creator><creator>Aranda, F</creator><creator>Mártir Alario, J M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0005-7502-2946</orcidid><orcidid>https://orcid.org/0009-0001-4750-6485</orcidid><orcidid>https://orcid.org/0009-0002-1545-4542</orcidid><orcidid>https://orcid.org/0009-0007-2607-1025</orcidid><orcidid>https://orcid.org/0009-0001-1080-3128</orcidid></search><sort><creationdate>20231201</creationdate><title>Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient</title><author>Moreno Izarra, J ; Brunst, A ; Carmona Álvarez, J A ; Aranda, F ; Mártir Alario, J M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c218t-79affacfc88810aca3547714f693753343220f15fed0c6989abf9e7445cfa66c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Glycopeptides - therapeutic use</topic><topic>Humans</topic><topic>Lipoglycopeptides - therapeutic use</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Neoplasms - drug therapy</topic><topic>Soft Tissue Infections - complications</topic><topic>Soft Tissue Infections - drug therapy</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcus aureus</topic><toplevel>online_resources</toplevel><creatorcontrib>Moreno Izarra, J</creatorcontrib><creatorcontrib>Brunst, A</creatorcontrib><creatorcontrib>Carmona Álvarez, J A</creatorcontrib><creatorcontrib>Aranda, F</creatorcontrib><creatorcontrib>Mártir Alario, J M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Revista española de quimioterapia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moreno Izarra, J</au><au>Brunst, A</au><au>Carmona Álvarez, J A</au><au>Aranda, F</au><au>Mártir Alario, J M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient</atitle><jtitle>Revista española de quimioterapia</jtitle><addtitle>Rev Esp Quimioter</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>36</volume><issue>6</issue><spage>645</spage><epage>647</epage><pages>645-647</pages><issn>0214-3429</issn><eissn>1988-9518</eissn><cop>Spain</cop><pmid>37818986</pmid><doi>10.37201/req/055.2023</doi><tpages>3</tpages><orcidid>https://orcid.org/0009-0005-7502-2946</orcidid><orcidid>https://orcid.org/0009-0001-4750-6485</orcidid><orcidid>https://orcid.org/0009-0002-1545-4542</orcidid><orcidid>https://orcid.org/0009-0007-2607-1025</orcidid><orcidid>https://orcid.org/0009-0001-1080-3128</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0214-3429
ispartof	Revista española de quimioterapia, 2023-12, Vol.36 (6), p.645-647
issn	0214-3429 1988-9518
language	eng ; spa
recordid	cdi_proquest_miscellaneous_2876638057
source	MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects	Anti-Bacterial Agents - therapeutic use Glycopeptides - therapeutic use Humans Lipoglycopeptides - therapeutic use Methicillin-Resistant Staphylococcus aureus Neoplasms - drug therapy Soft Tissue Infections - complications Soft Tissue Infections - drug therapy Staphylococcal Infections - drug therapy Staphylococcus aureus
title	Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T09%3A28%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20new%20therapeutic%20scenarios%20for%20oritavancin:%20severe%20bacteremic%20Staphylococcus%20aureus%20skin%20and%20soft%20tissue%20infection%20in%20a%20severely%20immunocompromised%20oncology%20patient&rft.jtitle=Revista%20espa%C3%B1ola%20de%20quimioterapia&rft.au=Moreno%20Izarra,%20J&rft.date=2023-12-01&rft.volume=36&rft.issue=6&rft.spage=645&rft.epage=647&rft.pages=645-647&rft.issn=0214-3429&rft.eissn=1988-9518&rft_id=info:doi/10.37201/req/055.2023&rft_dat=%3Cproquest_cross%3E2876638057%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2876638057&rft_id=info:pmid/37818986&rfr_iscdi=true